Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-14

Clinical Trial Update: Safety and Efficacy of ActiGraft Pro Compared to Standard of Care in DFUs [NA]

View source ↗

Summary

This trial update reports on the safety and efficacy of ActiGraft Pro versus standard of care in diabetic foot ulcers and chronic ulcers, with the study having …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ActiGraft Pro

Snippet

Sponsor: RedDress Ltd. | Conditions: Diabetic Foot, Chronic Ulcer | NA | Status: COMPLETED